Laws And Regulations

Type	Signature	Number	Date	Topic	Document
Circular	Minister of Public Health	9	9-3-2022	Related to providing specialized mental health medications in primary health care centers	Circular Number 9: Related to providing specialized mental health medications in primary health care centers
Decision	Minister of Public Health	271/1	25/02/2019	Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital	Decision Number 271/1: Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital
Decision	Minister of Public Health	270/1	25/02/2019	Related to the Quality of Care and Human Rights in the Field of Mental Health	Decision Number 270/1: Related to the Quality of Care of Human Rights in the Field of Mental Health
Circular	Director General	60	20/06/2018	Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system	Circular Number 60: Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system
Circular	Director General	112	27/11/2018	Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health	Circular Number 112: Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health
Circular	Director General	113	22/11/2018	Related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)	Circular number 113: related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)
Decision	Minister of Public Health	1155	19-06-2018	Decision related to the National Mental Health Programme	Decision number 1155: related to the National Mental Health Programme
Circular	Director General	22	09-03-2018	Regulation of studies and research in the field of mental health and psychosocial support	Circular number 22: related to the regulation of studies and research in the field of mental health and psychosocial support
Annexe		1320/1	02-2018	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.
Circular	Director General	48	12-06-2017	Regulation of research in the field of mental health	Circular number 48: Related to the regulation of research in the field of mental health
Circular	Director General	64	12-06-2017	Projects related to MHPSS and substance use in Lebanon	Circular number 64: Projects related to MHPSS and substance use in Lebanon
Circular	Director General	46	22-03-2016	Request to hospitals to not report on overdose	Circular number 46: related to the request to hospitals to not report on overdose

ATC	Name	B/G	Ingredients	Dosage	Form	Price
N02BE01	SOLUFLEX PARACETAMOL	G	Paracetamol - 1g/100ml	1g/100ml	Injectable solution	211,175 L.L
N05AH03	VAINCOR	G	Olanzapine - 5mg	5mg	Tablet, coated, scored	806,306 L.L
N06BA09	PMS-ATOMOXETINE	G	Atomoxetine (HCl) - 25mg	25mg	Capsule	4,121,565 L.L
S01CA01	API-TOBRASON	G	Dexamethasone - 1mg/g, Tobramycin - 3mg/g		Ointment	243,235 L.L
A02BC05	PUMPINOX	G	Esomeprazole - 40mg	40mg	Tablet, enteric coated	649,076 L.L
B03BB01	FOLICIL	G	Folic acid - 5mg	5mg	Tablet	584,571 L.L
B05XA03	0.9% SODIUM CHLORIDE INJECTION USP	G	Sodium chloride - 0.9%	0.9%	Injectable solution	181,570 L.L
C07AB03	BLOKIUM 50MG	G	Atenolol - 50mg	50mg	Tablet	186,794 L.L
D11AX01	ALOPEXY	G	Minoxidil - 5%	5%	Solution	896,343 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 1g	1g	Injectable powder for solution+diluent	643,765 L.L
J01XB01	COLIXIN	G	Colistimethate Sodium - 1,000,000IU	1,000,000IU	Injectable powder for solution, Inhalation powder	20,296,042 L.L
L01BA04	PEMETREXED NEAPOLIS	G	Pemetrexed (disodium) - 100mg	100mg	Injectable solution	10,554,169 L.L
M02AA15	GROFENAC	G	Diclofenac sodium - 1%		Emulsion Gel	314,459 L.L
N02BE01	? PARACETAMOL	G	Paracetamol - 1g/100ml	1g/100ml	Injectable solution	191,978 L.L
N05AH03	ZOLAPINE	G	Olanzapine - 5mg	5mg	Tablet, orodispersible	1,186,165 L.L
N06BA09	PMS-ATOMOXETINE	G	Atomoxetine (HCl) - 18mg	18mg	Capsule	3,744,073 L.L
R03BB04	TIOVA-T	G	Tiotropium bromide monohydrate - 18mcg	18mcg	Rotacaps	384,339 L.L
B03BB01	MED-FOLIC ACID	G	Folic acid - 5mg	5mg	Tablet, scored	355,798 L.L
B05XA03	0.9% SODIUM CHLORIDE INJECTION USP	G	Sodium chloride - 0.9%	0.9%	Injectable solution	141,349 L.L
C09DA03	ARBITEN PLUS	G	Valsartan - 160mg, Hydrochlorothiazide - 12.5mg		Tablet	544,256 L.L
C10AB05	FENOGAL	G	Fenofibrate micronised - 200mg	200mg	Capsule, micronized	392,402 L.L
D11AX01	HAIRGAINE 5	G	Minoxidil - 5%	5%	Solution	1,963,354 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 1g, Lidocaine (ampoule) -	1g	Injectable powder for solution+diluent	568,253 L.L
J01XB01	COLISTIMETHATE	G	Colistimethate Sodium - 150mg	150mg	Injectable powder for solution	38,239,924 L.L
L01BA04	PEMETREXED STRAGEN	G	Pemetrexed (disodium) - 100mg/4ml	100mg/4ml	Injectable concentrate for solution	12,759,187 L.L
M02AA15	LOCAGEL	G	Diclofenac sodium (diethylamine) - 10mg/g	10mg/g	Gel	223,078 L.L
N05AH03	ZYRWAN OD	G	Olanzapine - 5mg	5mg	Tablet, orodispersible	831,391 L.L
N06BA09	APO-ATOMOXETINE	G	Atomoxetine (HCl) - 10mg	10mg	Capsule	2,981,987 L.L
S01CA02	LOXTRA	G	Prednisolone acetate - 2mg/ml, Tetrahydrozoline HCl - 0.4mg/ml, Ofloxacin - 3mg/ml		Drops suspension	423,310 L.L
A02BC05	ESAC	G	Esomeprazole sodium - 40mg	40mg	Injectable powder for solution	430,030 L.L